make progress lower ep exit
challeng remain progress area
coti result in-lin organ sale y/i ahead profit
luxuri continu post strong growth organ sale vs profit
consum beauti cb remain weak vs partli de-stock
brazil profit spend support brand relaunch profession growth
in-lin profit year-ago ep beat bofaml/street
op profit vs model clearli still work drive
sustain turnaround help solidifi confid growth luxuri
unit keep debat squar coti abil turn cb compani
note sold shut brand repres cb sale slight
posit sale growth rate though dilut annual
lower ep put take ahead
trim ep beat off-set slightli lower sale fy
organ sale vs prior higher interest expens relaunch
covergirl progress still build full re-launch cours
shelf compris new product still major legaci
sku continu forecast organ sale management reiter
synergi deliv flow earn
though expect off-set support relaunch especi
all-in lower ep reflect
portfolio ration remaind mostli higher interest expens
lower po reiter buy rate
lower po target multipl new
ep target turn lower reflect lower multipl consum group clearli
still work toward turnaround cut estim albeit non-
op item int expens recent refinanc brand exit improv l-t
health busi howev luxuri show strong growth depend
busi recov cb relaunch roll synergi offer potenti
upsid ep see likelihood turnaround favor reiter buy
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
global manufactur market
distributor fragranc color cosmet
includ nail skin care global
fragranc categori color cosmet
fragranc account sale
cosmet account sale skin care
account sale geograph break-out
follow merger brand pg
beauti greater scale focu across
luxuri profession mass beauti
much work ahead need
significantli leverag new platform turn
around result share trade low rel
fundament opportun view
tabl coti result segment
organ sale driven co gucci bloom fragranc ck
one chloe nomad
organ sale includ month youniqu declin driven us brand
havent full re-launch price action brazil partli off-set
growth rest almea
organ sale driven gel restag strength lacquer
sale segment report
total compani report
sale
section pf pg
sale
sale
sale
sale
report pro forma combin coti pg beauti
organ ex-m fx
sg sale
amort sale
restructur
ep continu oper
sg sale
 sale
 sale
amort sale
restructur
ep continu oper
price object base target price-to-earnings ep
estim in-lin target multipl large-cap hpc group view
adequ balanc near-term challeng compani face number
action take improv growth well synergi come
downsid risk continu sluggish organ sale trend integr
loss signific licens agreement reinvest need macro slowdown
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
